Harnessing Single-Cell Multi-Omic Energy States for Integrated Cancer Biology
Learn how scientists use multi-omic approaches to identify functional changes that lead to cancer cell drug resistance and the development of new treatment strategies.
![[wpbb post:title]](https://isoplexis.com/wp-content/uploads/2021/02/harnessing-webinar-thumb-v2.jpg)
James R. Heath, PhD, President and Professor Institute for Systems Biology, Seattle and Sean Mackay, CEO and Co-Founder, IsoPlexis
Learn about the technological innovations that can help you dramatically accelerate your immunotherapies and drug development.
Explore several case studies showing how IsoPlexis highly multiplexed bulk & single-cell capabilities enabled researchers to capture complexities connected to in vivo biology.
